Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Rhabdoid Tumor

  • Jaclyn A. Biegel
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_5093-2


A highly malignant tumor that primarily affects infants and young children. Rhabdoid cells contain large nuclei with prominent nucleoli and abundant eosinophilic cytoplasm that often contains filamentous cytoplasmic inclusions. In tumors of the central nervous system (CNS), areas of rhabdoid cells may be seen in juxtaposition to areas of primitive neuroepithelial cells resembling primitive neuroectodermal tumor, as well as mesenchymal tissue and/or epithelial tissue. The designation atypical teratoid/rhabdoid tumor (AT/RT) is used to describe the CNS tumor.


The true incidence of rhabdoid tumors in the population is not known due to the fact that many of these malignancies, especially in the brain, have been misdiagnosed. The most common sites of presentation for rhabdoid tumor are the kidney and brain. Rhabdoid tumors account for approximately 1–2 % of childhood renal tumors and 2 % of pediatric CNS tumors (Brain Tumor). Extrarenal tumors are less common and...


Central Nervous System Tumor Primitive Neuroectodermal Tumor Rhabdoid Tumor Rhabdoid Cell Biallelic Inactivation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Biegel JA, Zhou JY, Rorke LB et al (1999) Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 59:74–79PubMedGoogle Scholar
  2. Biegel JA, Busse TM, Weissman BE (2014) SWI/SNF chromatin remodeling complexes and cancer. Am J Med Genet C Semin Med Genet 166C:350–366Google Scholar
  3. Eaton KW, Tooke LS, Wainwright LM et al (2011) Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56:7–15Google Scholar
  4. Foulkes WD, Clarke BA, Hasselblatt M et al (2014) No small surprise - small cell carcinoma of the ovary, hypercalcemic type, is a malignant rhabdoid tumor. J Pathol 233:209–214Google Scholar
  5. Geller JI, Roth JJ, Biegel JA (2015) Biology and Treatment of Rhabdoid Tumor. Crit Rev Oncog 20:199–216Google Scholar
  6. Hasselblatt M, Gesk S, Oyen F et al (2011) Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 35:933–935Google Scholar
  7. Judkins AR, Mauger J, Rorke LB et al (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric central nervous system neoplasms. Am J Surg Pathol 28:644–6502CrossRefPubMedGoogle Scholar
  8. Rorke LB, Packer RJ, Biegel JA (1996) Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 85:56–65CrossRefPubMedGoogle Scholar
  9. Schneppenheim R, Fruhwald MC, Gesk S (2010) Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 86:279–284Google Scholar
  10. Sevenet N, Lellouch-Tubiana A, Schofield D et al (1999) Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Human Mol Genet 8:2359–2368CrossRefGoogle Scholar
  11. Versteege I, Sevenet N, Lange J et al (1999) Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 394:203–207CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.Children’s Hospital of Los AngelesLos AngelesUSA